BRIEF published on 01/26/2026 at 18:05, 9 days 7 hours ago ABIVAX: Share capital and voting rights as of December 31, 2025 Voting Rights Biotechnology Actions AMF Abivax
BRIEF published on 01/26/2026 at 18:05, 9 days 7 hours ago ABIVAX : Composition du capital social et droits de vote au 31 décembre 2025 Droits De Vote Biotechnologie Actions AMF Abivax
PRESS RELEASE published on 01/26/2026 at 18:00, 9 days 7 hours ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.12.25. ABIVAX annonce le nombre d'actions et de droits de vote au 31.12.25. Société de biotechnologie axée sur les traitements thérapeutiques dans les maladies inflammatoires chroniques Droits De Vote Biotechnologie Actions Abivax Maladies Inflammatoires
BRIEF published on 01/07/2026 at 22:10, 28 days 3 hours ago Abivax unveils its objectives for 2026 Abivax Obefazimod Phase 3 2026 RCH
BRIEF published on 01/07/2026 at 22:10, 28 days 3 hours ago Abivax dévoile ses objectifs pour 2026 Abivax Obefazimod Phase 3 2026 RCH
BRIEF published on 01/07/2026 at 22:10, 28 days 3 hours ago Abivax Reveals Strategic Plans for 2026 Regulatory Filing Abivax 2026 Outlook Ulcerative Colitis Market Obefazimod Trials Crohn’s Disease Research
BRIEF published on 01/07/2026 at 22:10, 28 days 3 hours ago Abivax dévoile ses plans stratégiques pour 2026 Dépôt Réglementaire Perspectives D'Abivax Pour 2026 Marché De La Colite Ulcéreuse Essais Cliniques Sur L'obefazimod Recherche Sur La Maladie De Crohn
PRESS RELEASE published on 01/07/2026 at 22:05, 28 days 3 hours ago Abivax présente ses perspectives pour 2026 Abivax présente ses perspectives pour 2026, annonçant des nouveautés dans le traitement de la rectocolite hémorragique, les progrès des essais ABTECT-UC et ENHANCE-CD, et l'avancement de son portefeuille de candidats médicaments Abivax Maladies Inflammatoires Chroniques Rectocolite Hémorragique Essais Cliniques Perspectives 2026
PRESS RELEASE published on 01/07/2026 at 22:05, 28 days 3 hours ago Abivax Provides 2026 Corporate Outlook Abivax provides 2026 corporate outlook, highlighting market insights, trial progress, and pipeline advancements in treating chronic inflammatory diseases like UC and CD Abivax Chronic Inflammatory Diseases 2026 Corporate Outlook UC CD
BRIEF published on 12/18/2025 at 22:10, 1 month 17 days ago Abivax joins the Nasdaq Biotechnology index Biotechnology Abivax Obefazimod Ulcerative Colitis Nasdaq Biotechnology
Published on 02/05/2026 at 01:35, 13 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 1 hour 48 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 3 hours 23 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 9 hours 33 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 4 hours 54 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 5 hours 12 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 5 hours 47 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 6 hours 53 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 7 hours 7 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 7 hours 44 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 7 hours 44 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 8 hours 3 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 8 hours 3 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
